Anastrozol - off‑label použití u mužů

Warning

This publication doesn't include Faculty of Arts. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Title in English Anastrozole - off-label use in men
Authors

TURJAP Miroslav KRÁL Roman JUŘICA Jan

Year of publication 2023
Type Article in Periodical
Magazine / Source Farmacie pro praxi - Praktické lékárenství
MU Faculty or unit

Faculty of Medicine

Citation
web https://www.solen.cz/artkey/lek-202301-0002_anastrozol_-_off_8209_label_pouziti_u_muzu.php
Keywords anastrozole; aromatase inhibitors; men; off-label use; clinical trials
Description Anastrozole is a highly selective nonsteroidal aromatase inhibitor. It is approved for the treatment of hormone receptor-positive breast cancer in postmenopausal women. Nonetheless, aromatase inhibitors have also been used off-label for many years in men. This article outlines empirical non-oncological anastrozole uses in men and briefly presents some current clinical trials involving the male population.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

By clicking “Accept Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Settings

Necessary Only Accept Cookies